カテゴリ： 世界, 医療/バイオ, QYResearch

アドレナリン受容体遮断薬の世界市場2023年：アルファブロッカー、ベータブロッカー、その他

■ 英語タイトル：Global Adrenoceptor Blocking Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8659）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8659
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アドレナリン受容体遮断薬の世界市場2023年：アルファブロッカー、ベータブロッカー、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はアドレナリン受容体遮断薬のグローバル市場について調査・分析し、世界のアドレナリン受容体遮断薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（アルファブロッカー、ベータブロッカー、その他）、用途別セグメント分析（心臓病、高血圧、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer、Prometheus Laboratories、Baxter、Novartis、AstraZeneca Pharmaceuticals、Sanofi、Novitium Pharma、Sun Pharmaceutical Industries、Granules、Mylanなどが含まれています。アドレナリン受容体遮断薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、アドレナリン受容体遮断薬市場規模を算出する際に考慮しました。

・アドレナリン受容体遮断薬市場の概要
- アドレナリン受容体遮断薬の種類別セグメント
- 世界のアドレナリン受容体遮断薬市場規模：タイプ別分析（アルファブロッカー、ベータブロッカー、その他）
- アドレナリン受容体遮断薬の用途別セグメント
- 世界のアドレナリン受容体遮断薬市場規模：用途別分析（心臓病、高血圧、その他）
- 世界のアドレナリン受容体遮断薬市場規模予測（2018年-2029年）

・アドレナリン受容体遮断薬市場の成長トレンド
- アドレナリン受容体遮断薬の地域別市場規模（2018年-2029年）
- アドレナリン受容体遮断薬市場ダイナミクス
- アドレナリン受容体遮断薬の業界動向
- アドレナリン受容体遮断薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：アルファブロッカー、ベータブロッカー、その他
- 世界のアドレナリン受容体遮断薬のタイプ別市場規模（2018年-2023年）
- 世界のアドレナリン受容体遮断薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：心臓病、高血圧、その他
- 世界のアドレナリン受容体遮断薬の用途別市場規模（2018年-2023年）
- 世界のアドレナリン受容体遮断薬の用途別市場規模（2024年-2029年）

・アドレナリン受容体遮断薬の地域別市場規模
- 北米のアドレナリン受容体遮断薬市場規模（2018年-2029年）
- 米国のアドレナリン受容体遮断薬市場規模（2018年-2029年）
- ヨーロッパのアドレナリン受容体遮断薬市場規模（2018年-2029年）
- アジア太平洋のアドレナリン受容体遮断薬市場規模（2018年-2029年）
- 中国のアドレナリン受容体遮断薬市場規模（2018年-2029年）
- 日本のアドレナリン受容体遮断薬市場規模（2018年-2029年）
- 韓国のアドレナリン受容体遮断薬市場規模（2018年-2029年）
- インドのアドレナリン受容体遮断薬市場規模（2018年-2029年）
- オーストラリアのアドレナリン受容体遮断薬市場規模（2018年-2029年）
- 中南米のアドレナリン受容体遮断薬市場規模（2018年-2029年）
- 中東・アフリカのアドレナリン受容体遮断薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Pfizer、Prometheus Laboratories、Baxter、Novartis、AstraZeneca Pharmaceuticals、Sanofi、Novitium Pharma、Sun Pharmaceutical Industries、Granules、Mylan

・アナリストの観点/結論

・調査手法と情報源

Adrenoceptor Blocking Drugs Block Adrenergic Receptors and Thus Antagonize the Action of Noradrenergic Neurotransmitters or Adrenergic Receptor Agonists. in Whole Animals, the Strength of Their Action Depends on the Noradrenergic Tone of the Body.
Highlights
The global Adrenoceptor Blocking Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Adrenoceptor Blocking Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Adrenoceptor Blocking Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Adrenoceptor Blocking Drugs in Heart Disease is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Adrenoceptor Blocking Drugs include Pfizer, Prometheus Laboratories, Baxter, Novartis, AstraZeneca Pharmaceuticals, Sanofi, Novitium Pharma, Sun Pharmaceutical Industries and Granules, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Adrenoceptor Blocking Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adrenoceptor Blocking Drugs.
The Adrenoceptor Blocking Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Adrenoceptor Blocking Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adrenoceptor Blocking Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer
Prometheus Laboratories
Baxter
Novartis
AstraZeneca Pharmaceuticals
Sanofi
Novitium Pharma
Sun Pharmaceutical Industries
Granules
Mylan
Segment by Type
Alpha Blockers
Beta Blockers
Others
Segment by Application
Heart Disease
Hypertension
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adrenoceptor Blocking Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adrenoceptor Blocking Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Alpha Blockers
1.2.3 Beta Blockers
1.2.4 Others
1.3 Market by Application
1.3.1 Global Adrenoceptor Blocking Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Heart Disease
1.3.3 Hypertension
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adrenoceptor Blocking Drugs Market Perspective (2018-2029)
2.2 Adrenoceptor Blocking Drugs Growth Trends by Region
2.2.1 Global Adrenoceptor Blocking Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Adrenoceptor Blocking Drugs Historic Market Size by Region (2018-2023)
2.2.3 Adrenoceptor Blocking Drugs Forecasted Market Size by Region (2024-2029)
2.3 Adrenoceptor Blocking Drugs Market Dynamics
2.3.1 Adrenoceptor Blocking Drugs Industry Trends
2.3.2 Adrenoceptor Blocking Drugs Market Drivers
2.3.3 Adrenoceptor Blocking Drugs Market Challenges
2.3.4 Adrenoceptor Blocking Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adrenoceptor Blocking Drugs Players by Revenue
3.1.1 Global Top Adrenoceptor Blocking Drugs Players by Revenue (2018-2023)
3.1.2 Global Adrenoceptor Blocking Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Adrenoceptor Blocking Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adrenoceptor Blocking Drugs Revenue
3.4 Global Adrenoceptor Blocking Drugs Market Concentration Ratio
3.4.1 Global Adrenoceptor Blocking Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adrenoceptor Blocking Drugs Revenue in 2022
3.5 Adrenoceptor Blocking Drugs Key Players Head office and Area Served
3.6 Key Players Adrenoceptor Blocking Drugs Product Solution and Service
3.7 Date of Enter into Adrenoceptor Blocking Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adrenoceptor Blocking Drugs Breakdown Data by Type
4.1 Global Adrenoceptor Blocking Drugs Historic Market Size by Type (2018-2023)
4.2 Global Adrenoceptor Blocking Drugs Forecasted Market Size by Type (2024-2029)
5 Adrenoceptor Blocking Drugs Breakdown Data by Application
5.1 Global Adrenoceptor Blocking Drugs Historic Market Size by Application (2018-2023)
5.2 Global Adrenoceptor Blocking Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Adrenoceptor Blocking Drugs Market Size (2018-2029)
6.2 North America Adrenoceptor Blocking Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Adrenoceptor Blocking Drugs Market Size by Country (2018-2023)
6.4 North America Adrenoceptor Blocking Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adrenoceptor Blocking Drugs Market Size (2018-2029)
7.2 Europe Adrenoceptor Blocking Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Adrenoceptor Blocking Drugs Market Size by Country (2018-2023)
7.4 Europe Adrenoceptor Blocking Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adrenoceptor Blocking Drugs Market Size (2018-2029)
8.2 Asia-Pacific Adrenoceptor Blocking Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Adrenoceptor Blocking Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Adrenoceptor Blocking Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adrenoceptor Blocking Drugs Market Size (2018-2029)
9.2 Latin America Adrenoceptor Blocking Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Adrenoceptor Blocking Drugs Market Size by Country (2018-2023)
9.4 Latin America Adrenoceptor Blocking Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adrenoceptor Blocking Drugs Market Size (2018-2029)
10.2 Middle East & Africa Adrenoceptor Blocking Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Adrenoceptor Blocking Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Adrenoceptor Blocking Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Adrenoceptor Blocking Drugs Introduction
11.1.4 Pfizer Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Prometheus Laboratories
11.2.1 Prometheus Laboratories Company Detail
11.2.2 Prometheus Laboratories Business Overview
11.2.3 Prometheus Laboratories Adrenoceptor Blocking Drugs Introduction
11.2.4 Prometheus Laboratories Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.2.5 Prometheus Laboratories Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Adrenoceptor Blocking Drugs Introduction
11.3.4 Baxter Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.3.5 Baxter Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Adrenoceptor Blocking Drugs Introduction
11.4.4 Novartis Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 AstraZeneca Pharmaceuticals
11.5.1 AstraZeneca Pharmaceuticals Company Detail
11.5.2 AstraZeneca Pharmaceuticals Business Overview
11.5.3 AstraZeneca Pharmaceuticals Adrenoceptor Blocking Drugs Introduction
11.5.4 AstraZeneca Pharmaceuticals Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.5.5 AstraZeneca Pharmaceuticals Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Adrenoceptor Blocking Drugs Introduction
11.6.4 Sanofi Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Novitium Pharma
11.7.1 Novitium Pharma Company Detail
11.7.2 Novitium Pharma Business Overview
11.7.3 Novitium Pharma Adrenoceptor Blocking Drugs Introduction
11.7.4 Novitium Pharma Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.7.5 Novitium Pharma Recent Development
11.8 Sun Pharmaceutical Industries
11.8.1 Sun Pharmaceutical Industries Company Detail
11.8.2 Sun Pharmaceutical Industries Business Overview
11.8.3 Sun Pharmaceutical Industries Adrenoceptor Blocking Drugs Introduction
11.8.4 Sun Pharmaceutical Industries Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.8.5 Sun Pharmaceutical Industries Recent Development
11.9 Granules
11.9.1 Granules Company Detail
11.9.2 Granules Business Overview
11.9.3 Granules Adrenoceptor Blocking Drugs Introduction
11.9.4 Granules Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.9.5 Granules Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Adrenoceptor Blocking Drugs Introduction
11.10.4 Mylan Revenue in Adrenoceptor Blocking Drugs Business (2018-2023)
11.10.5 Mylan Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Adrenoceptor Blocking Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Alpha Blockers
Table 3. Key Players of Beta Blockers
Table 4. Key Players of Others
Table 5. Global Adrenoceptor Blocking Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Adrenoceptor Blocking Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Adrenoceptor Blocking Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Adrenoceptor Blocking Drugs Market Share by Region (2018-2023)
Table 9. Global Adrenoceptor Blocking Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Adrenoceptor Blocking Drugs Market Share by Region (2024-2029)
Table 11. Adrenoceptor Blocking Drugs Market Trends
Table 12. Adrenoceptor Blocking Drugs Market Drivers
Table 13. Adrenoceptor Blocking Drugs Market Challenges
Table 14. Adrenoceptor Blocking Drugs Market Restraints
Table 15. Global Adrenoceptor Blocking Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Adrenoceptor Blocking Drugs Market Share by Players (2018-2023)
Table 17. Global Top Adrenoceptor Blocking Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenoceptor Blocking Drugs as of 2022)
Table 18. Ranking of Global Top Adrenoceptor Blocking Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Adrenoceptor Blocking Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Adrenoceptor Blocking Drugs Product Solution and Service
Table 22. Date of Enter into Adrenoceptor Blocking Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Adrenoceptor Blocking Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Adrenoceptor Blocking Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Adrenoceptor Blocking Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Adrenoceptor Blocking Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Adrenoceptor Blocking Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Adrenoceptor Blocking Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Adrenoceptor Blocking Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Adrenoceptor Blocking Drugs Revenue Market Share by Application (2024-2029)
Table 32. North America Adrenoceptor Blocking Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Adrenoceptor Blocking Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Adrenoceptor Blocking Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Adrenoceptor Blocking Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Adrenoceptor Blocking Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Adrenoceptor Blocking Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Adrenoceptor Blocking Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Adrenoceptor Blocking Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Adrenoceptor Blocking Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Adrenoceptor Blocking Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Adrenoceptor Blocking Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Adrenoceptor Blocking Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Adrenoceptor Blocking Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Adrenoceptor Blocking Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Adrenoceptor Blocking Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Adrenoceptor Blocking Drugs Product
Table 50. Pfizer Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Prometheus Laboratories Company Detail
Table 53. Prometheus Laboratories Business Overview
Table 54. Prometheus Laboratories Adrenoceptor Blocking Drugs Product
Table 55. Prometheus Laboratories Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 56. Prometheus Laboratories Recent Development
Table 57. Baxter Company Detail
Table 58. Baxter Business Overview
Table 59. Baxter Adrenoceptor Blocking Drugs Product
Table 60. Baxter Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 61. Baxter Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Adrenoceptor Blocking Drugs Product
Table 65. Novartis Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. AstraZeneca Pharmaceuticals Company Detail
Table 68. AstraZeneca Pharmaceuticals Business Overview
Table 69. AstraZeneca Pharmaceuticals Adrenoceptor Blocking Drugs Product
Table 70. AstraZeneca Pharmaceuticals Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 71. AstraZeneca Pharmaceuticals Recent Development
Table 72. Sanofi Company Detail
Table 73. Sanofi Business Overview
Table 74. Sanofi Adrenoceptor Blocking Drugs Product
Table 75. Sanofi Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Novitium Pharma Company Detail
Table 78. Novitium Pharma Business Overview
Table 79. Novitium Pharma Adrenoceptor Blocking Drugs Product
Table 80. Novitium Pharma Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 81. Novitium Pharma Recent Development
Table 82. Sun Pharmaceutical Industries Company Detail
Table 83. Sun Pharmaceutical Industries Business Overview
Table 84. Sun Pharmaceutical Industries Adrenoceptor Blocking Drugs Product
Table 85. Sun Pharmaceutical Industries Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 86. Sun Pharmaceutical Industries Recent Development
Table 87. Granules Company Detail
Table 88. Granules Business Overview
Table 89. Granules Adrenoceptor Blocking Drugs Product
Table 90. Granules Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 91. Granules Recent Development
Table 92. Mylan Company Detail
Table 93. Mylan Business Overview
Table 94. Mylan Adrenoceptor Blocking Drugs Product
Table 95. Mylan Revenue in Adrenoceptor Blocking Drugs Business (2018-2023) & (US$ Million)
Table 96. Mylan Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adrenoceptor Blocking Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Adrenoceptor Blocking Drugs Market Share by Type: 2022 VS 2029
Figure 3. Alpha Blockers Features
Figure 4. Beta Blockers Features
Figure 5. Others Features
Figure 6. Global Adrenoceptor Blocking Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Adrenoceptor Blocking Drugs Market Share by Application: 2022 VS 2029
Figure 8. Heart Disease Case Studies
Figure 9. Hypertension Case Studies
Figure 10. Others Case Studies
Figure 11. Adrenoceptor Blocking Drugs Report Years Considered
Figure 12. Global Adrenoceptor Blocking Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Adrenoceptor Blocking Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Adrenoceptor Blocking Drugs Market Share by Region: 2022 VS 2029
Figure 15. Global Adrenoceptor Blocking Drugs Market Share by Players in 2022
Figure 16. Global Top Adrenoceptor Blocking Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenoceptor Blocking Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Adrenoceptor Blocking Drugs Revenue in 2022
Figure 18. North America Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Adrenoceptor Blocking Drugs Market Share by Country (2018-2029)
Figure 20. United States Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Adrenoceptor Blocking Drugs Market Share by Country (2018-2029)
Figure 24. Germany Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Adrenoceptor Blocking Drugs Market Share by Region (2018-2029)
Figure 32. China Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Adrenoceptor Blocking Drugs Market Share by Country (2018-2029)
Figure 40. Mexico Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Adrenoceptor Blocking Drugs Market Share by Country (2018-2029)
Figure 44. Turkey Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Adrenoceptor Blocking Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 47. Prometheus Laboratories Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 48. Baxter Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 50. AstraZeneca Pharmaceuticals Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 52. Novitium Pharma Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 53. Sun Pharmaceutical Industries Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 54. Granules Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 55. Mylan Revenue Growth Rate in Adrenoceptor Blocking Drugs Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血液腫瘍薬の世界市場2023年：化学療法、標的療法、免疫療法、その他
  • 脂肪肝治療薬の世界市場2023年：ALD、NAFLD
  • S1P受容体調節薬の世界市場2023年：フィンゴリモド、オザニモド、シポニモド、その他
  • 貧血治療薬の世界市場2023年：サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤
  • 高カリウム血症治療薬の世界市場2023年：パティロマー、シクロケイ酸ジルコニウムナトリウム
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8659 )"アドレナリン受容体遮断薬の世界市場2023年：アルファブロッカー、ベータブロッカー、その他" (英文：Global Adrenoceptor Blocking Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。